RadNet Inc. Common Stock (RDNT)
Stock · NASDAQ · Health Care
$68.86as of 10/16/2026
Price chart
Active signals
RDNT Signal Track Record
How signals performed across all stocks →What RDNT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 34 | +1.9% | 56% | September 18, 2026 |
| Bollinger Band Breakout | 25 | +5.2% | 68% | August 4, 2026 |
| Bollinger Band Breakdown | 23 | +8.3% | 70% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -1.1% | 45% | August 5, 2026 |
| Any 20-session window (baseline) | +2.1% | 59% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 11,000
- Website
- www.radnet.com/
Fundamentals
- 1-day range
- $68.51$70.44
- Market cap
- $5.36B
- P/E (trailing)
- —
- P/E (forward)
- 77.59
- EPS (trailing)
- $-0.28
- Dividend yield
- —
- Beta
- 1.43
- Avg. volume
- 695.6K
How RadNet Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
8 analyst ratings
RadNet Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- RDNTRadNet Inc. Common Stock$68.8▼ 2.29%Market cap $5.36BP/E —$50.82$85.84
- CAICaris Life Sciences Inc. Common Stock$30.56▼ 3.78%Market cap $5.65BP/E 76.07$14.19$33.66
- CELCCelcuity Inc. Common Stock$56.58▼ 6.17%Market cap $4.55BP/E —$46.51$151.02
- BLLNBillionToOne Inc. Class A Common Stock$98.12▼ 4.49%Market cap $4.22BP/E 128.54$61.96$150.44
- CONConcentra Group Holdings Parent Inc. Common Stock$38.54▼ 1.56%Market cap $3.91BP/E 24.09$18.55$38.07
- VCYTVeracyte Inc. Common Stock$43.12▼ 2.86%Market cap $3.71BP/E 31.17$29.46$60.91
- ACHCAcadia Healthcare Company Inc. Common Stock$29.98▼ 3.41%Market cap $2.86BP/E —$11.43$35.83
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RDNT RadNet Inc. Common Stock | $5.36B | — | $68.8 | ▼ 2.29% | $50.82$85.84 |
| CAI Caris Life Sciences Inc. Common Stock | $5.65B | 76.07 | $30.56 | ▼ 3.78% | $14.19$33.66 |
| CELC Celcuity Inc. Common Stock | $4.55B | — | $56.58 | ▼ 6.17% | $46.51$151.02 |
| BLLN BillionToOne Inc. Class A Common Stock | $4.22B | 128.54 | $98.12 | ▼ 4.49% | $61.96$150.44 |
| CON Concentra Group Holdings Parent Inc. Common Stock | $3.91B | 24.09 | $38.54 | ▼ 1.56% | $18.55$38.07 |
| VCYT Veracyte Inc. Common Stock | $3.71B | 31.17 | $43.12 | ▼ 2.86% | $29.46$60.91 |
| ACHC Acadia Healthcare Company Inc. Common Stock | $2.86B | — | $29.98 | ▼ 3.41% | $11.43$35.83 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Here’s How Much You Would Have Made Owning RadNet Stock In The Last 15 Yearsbenzinga · 10/13/2026
- Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top MarksYahoo · 10/8/2026
- New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate BiopsiesYahoo · 10/8/2026
- 3 Profitable Stocks That Fall ShortYahoo · 10/1/2026
- RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging ProfessionalsYahoo · 10/1/2026
- Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This PointYahoo · 9/18/2026
- 1 High-Flying Stock Worth Your Attention and 2 We IgnoreYahoo · 9/18/2026
- The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?Yahoo · 9/17/2026
- RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeekingAlpha · 9/16/2026
Insider Activity
Insider Actions →- David L. Swartz · June 18, 2026 · Sale2.7K @ $53.89
- Howard G. Berger · June 16, 2026 · Gift90
- Stephen M. Forthuber · June 15, 2026 · Sale19.9K @ $58.61
- Stephen M. Forthuber · June 15, 2026 · Sale24.2K @ $57.79
- Laura Pastre Jacobs · June 2, 2026 · Grant2.9K
- Gregory E. Spurlock · June 2, 2026 · Grant2.9K
- Lawrence L. Levitt · June 2, 2026 · Grant2.9K
- David L. Swartz · June 2, 2026 · Grant2.9K
- Howard G. Berger · May 5, 2026 · Option Exercise26.0K @ $18.64
Institutional Ownership
March 31, 2026
- Total shares held
- 72.61M
- Total value held
- $3.68B
- Institutional holders
- 334
- Unknown10.04M
- Unknown4.29M
- Unknown4.15M
- Unknown3.17M
- Unknown3.11M
- Unknown2.65M
- Unknown1.72M
- Unknown1.63M
- Unknown1.42M
- Unknown1.41M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
RadNet Q2 Earnings and AI Study News
RadNet received positive marks for its second-quarter testing and diagnostics services earnings. Additionally, a new study suggests DeepHealth AI could help avoid nearly one in five prostate biopsies. These developments provide context for the stock's current position within its 52-week range.
RadNet Q2 Earnings and AI Study News. RadNet received positive marks for its second-quarter testing and diagnostics services earnings. Additionally, a new study suggests DeepHealth AI could help avoid nearly one in five prostate biopsies. These developments provide context for the stock's current position within its 52-week range.